Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
Go back to Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain| TREVENA (NASDAQ: TRVN) | Delayed: 2.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.50 | 52 Week High | $13.02 | |||
| Open | $2.50 | 52 Week Low | $3.76 | |||
| Day High | $2.50 | P/E | N/A | |||
| Day Low | $2.50 | EPS | $-1.53 | |||
| Volume | 4 | |||||
